Impact of HIV and chronic kidney disease comorbidities on hepatitis C treatment choices, drug –drug interactions and hepatitis C cure
Conclusion This study shows that treatment pathways permitting access to individual treatment adjustments in accordance with comorbidities and with consideration of drug –drug interaction in a multi-disciplinary team, provides successful outcomes in hepatitis C patients co-morbid with HIV or chronic kidney disease.
Source: International Journal of Clinical Pharmacy - Category: Drugs & Pharmacology Source Type: research
More News: Chronic Kidney Disease | Drugs & Pharmacology | Hepatitis | Hepatitis C | Liver | Study | UK Health | Urology & Nephrology | Virology